Clinical Trial Update: Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a cisplatin-epinephrine injectable gel in combination with paclitaxel and carboplatin for recurrent head and neck cancer; curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• EPINEPHRINE (EPINEPHRINE)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Matrix Pharmaceutical | Conditions: Head and Neck Cancer | Phase 2 | Status: UNKNOWN